NLGN1 and attention deficit-hyperactivity disorder: The choice of D-cycloserine was informed by previous findings that this compound showed preclinical benefits in Neuroligin 1 KO mice (human autism and mental retardation) [64] and Tourette syndrome with accompanying ADHD and/or OCD [65].